Yvonne L Greenstreet's most recent trade in Alnylam Pharmaceuticals Inc was a trade of 973 Common Stock done at an average price of $323.8 . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 323.84 per share. | 04 Mar 2026 | 973 | 96,305 (0%) | 0% | 323.8 | 315,096 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 323.01 per share. | 04 Mar 2026 | 444 | 97,278 (0%) | 0% | 323.0 | 143,416 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 321.82 per share. | 04 Mar 2026 | 368 | 97,722 (0%) | 0% | 321.8 | 118,430 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 324.88 per share. | 04 Mar 2026 | 345 | 95,960 (0%) | 0% | 324.9 | 112,084 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 320.81 per share. | 04 Mar 2026 | 274 | 98,090 (0%) | 0% | 320.8 | 87,902 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 325.67 per share. | 04 Mar 2026 | 265 | 95,695 (0%) | 0% | 325.7 | 86,303 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 319.03 per share. | 04 Mar 2026 | 135 | 98,493 (0%) | 0% | 319.0 | 43,069 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 320.01 per share. | 04 Mar 2026 | 129 | 98,364 (0%) | 0% | 320.0 | 41,281 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2026 | 19,003 | 87,988 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 365.56 per share. | 11 Jan 2026 | 1,395 | 80,264 (0%) | 0% | 365.6 | 509,956 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 364.83 per share. | 11 Jan 2026 | 1,259 | 81,659 (0%) | 0% | 364.8 | 459,321 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 360.22 per share. | 11 Jan 2026 | 980 | 84,307 (0%) | 0% | 360.2 | 353,016 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 358.18 per share. | 11 Jan 2026 | 778 | 85,824 (0%) | 0% | 358.2 | 278,664 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 361.45 per share. | 11 Jan 2026 | 624 | 83,683 (0%) | 0% | 361.5 | 225,545 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 357.17 per share. | 11 Jan 2026 | 607 | 86,602 (0%) | 0% | 357.2 | 216,802 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 368.62 per share. | 11 Jan 2026 | 584 | 79,103 (0%) | 0% | 368.6 | 215,274 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 359.14 per share. | 11 Jan 2026 | 537 | 85,287 (0%) | 0% | 359.1 | 192,858 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 362.38 per share. | 11 Jan 2026 | 464 | 83,219 (0%) | 0% | 362.4 | 168,144 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 366.41 per share. | 11 Jan 2026 | 316 | 79,948 (0%) | 0% | 366.4 | 115,786 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 363.55 per share. | 11 Jan 2026 | 301 | 82,918 (0%) | 0% | 363.6 | 109,429 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 355.16 per share. | 11 Jan 2026 | 269 | 87,472 (0%) | 0% | 355.2 | 95,538 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 356.09 per share. | 11 Jan 2026 | 263 | 87,209 (0%) | 0% | 356.1 | 93,652 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 367.40 per share. | 11 Jan 2026 | 261 | 79,687 (0%) | 0% | 367.4 | 95,891 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 369.48 per share. | 11 Jan 2026 | 253 | 78,850 (0%) | 0% | 369.5 | 93,478 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 353.95 per share. | 11 Jan 2026 | 247 | 87,741 (0%) | 0% | 354.0 | 87,426 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 375.65 per share. | 11 Jan 2026 | 118 | 78,505 (0%) | 0% | 375.7 | 44,327 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 370.87 per share. | 11 Jan 2026 | 118 | 78,732 (0%) | 0% | 370.9 | 43,763 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 377.82 per share. | 11 Jan 2026 | 94 | 78,411 (0%) | 0% | 377.8 | 35,515 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 374.44 per share. | 11 Jan 2026 | 88 | 78,623 (0%) | 0% | 374.4 | 32,951 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 372.48 per share. | 11 Jan 2026 | 21 | 78,711 (0%) | 0% | 372.5 | 7,822 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.00 per share. | 26 Nov 2025 | 2,352 | 68,600 (0%) | 0% | 85 | 199,920 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 2,352 | 0 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 445.12 per share. | 26 Nov 2025 | 1,121 | 68,985 (0%) | 0% | 445.1 | 498,980 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.05 per share. | 26 Nov 2025 | 847 | 69,447 (0%) | 0% | 118.0 | 99,988 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 847 | 0 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.13 per share. | 26 Nov 2025 | 839 | 66,248 (0%) | 0% | 119.1 | 99,950 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 839 | 0 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 151.59 per share. | 26 Nov 2025 | 659 | 70,106 (0%) | 0% | 151.6 | 99,898 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 659 | 28,141 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.13 per share. | 12 Nov 2025 | 15,000 | 81,059 (0%) | 0% | 119.1 | 1,786,950 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 15,000 | 10,000 | - | - | Performance Stock Option 2017 (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 10,000 | 0 | - | - | Performance Stock Option 2017 (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.13 per share. | 12 Nov 2025 | 10,000 | 75,409 (0%) | 0% | 119.1 | 1,191,300 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 455.56 per share. | 12 Nov 2025 | 3,406 | 68,863 (0%) | 0% | 455.6 | 1,551,637 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 456.64 per share. | 12 Nov 2025 | 2,420 | 66,443 (0%) | 0% | 456.6 | 1,105,069 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 450.69 per share. | 12 Nov 2025 | 2,218 | 70,047 (0%) | 0% | 450.7 | 999,630 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 449.15 per share. | 12 Nov 2025 | 2,132 | 78,216 (0%) | 0% | 449.2 | 957,588 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 454.84 per share. | 12 Nov 2025 | 1,960 | 72,269 (0%) | 0% | 454.8 | 891,486 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 451.94 per share. | 12 Nov 2025 | 1,702 | 68,345 (0%) | 0% | 451.9 | 769,202 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 452.85 per share. | 12 Nov 2025 | 1,599 | 66,746 (0%) | 0% | 452.8 | 724,107 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 450.02 per share. | 12 Nov 2025 | 1,477 | 72,265 (0%) | 0% | 450.0 | 664,680 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 451.16 per share. | 12 Nov 2025 | 1,255 | 76,508 (0%) | 0% | 451.2 | 566,206 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 452.43 per share. | 12 Nov 2025 | 1,210 | 75,298 (0%) | 0% | 452.4 | 547,440 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 453.52 per share. | 12 Nov 2025 | 1,069 | 74,229 (0%) | 0% | 453.5 | 484,813 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 448.76 per share. | 12 Nov 2025 | 1,013 | 73,742 (0%) | 0% | 448.8 | 454,594 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 453.99 per share. | 12 Nov 2025 | 881 | 65,865 (0%) | 0% | 454.0 | 399,965 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 448.07 per share. | 12 Nov 2025 | 711 | 80,348 (0%) | 0% | 448.1 | 318,578 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 447.73 per share. | 12 Nov 2025 | 654 | 74,755 (0%) | 0% | 447.7 | 292,815 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.22 per share. | 12 Nov 2025 | 650 | 66,059 (0%) | 0% | 42.2 | 27,443 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 650 | 0 | - | - | Performance Stock Option 2016 (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 457.71 per share. | 12 Nov 2025 | 604 | 65,839 (0%) | 0% | 457.7 | 276,457 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 450.17 per share. | 12 Nov 2025 | 453 | 77,763 (0%) | 0% | 450.2 | 203,927 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 458.42 per share. | 12 Nov 2025 | 430 | 65,409 (0%) | 0% | 458.4 | 197,121 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 456.03 per share. | 12 Nov 2025 | 261 | 65,409 (0%) | 0% | 456.0 | 119,024 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 454.69 per share. | 12 Nov 2025 | 195 | 65,670 (0%) | 0% | 454.7 | 88,665 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 14,252 | 74,333 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 3,860 | 60,081 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 452.69 per share. | 01 Oct 2025 | 2,029 | 67,825 (0%) | 0% | 452.7 | 918,508 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 450.81 per share. | 01 Oct 2025 | 1,642 | 70,864 (0%) | 0% | 450.8 | 740,230 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 451.86 per share. | 01 Oct 2025 | 1,010 | 69,854 (0%) | 0% | 451.9 | 456,379 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 453.77 per share. | 01 Oct 2025 | 999 | 66,826 (0%) | 0% | 453.8 | 453,316 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 449.79 per share. | 01 Oct 2025 | 758 | 72,506 (0%) | 0% | 449.8 | 340,941 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 454.84 per share. | 01 Oct 2025 | 741 | 66,085 (0%) | 0% | 454.8 | 337,036 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 448.77 per share. | 01 Oct 2025 | 548 | 73,264 (0%) | 0% | 448.8 | 245,926 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 457.43 per share. | 01 Oct 2025 | 446 | 65,418 (0%) | 0% | 457.4 | 204,014 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 446.53 per share. | 01 Oct 2025 | 350 | 73,983 (0%) | 0% | 446.5 | 156,286 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 455.82 per share. | 01 Oct 2025 | 221 | 65,864 (0%) | 0% | 455.8 | 100,736 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 447.92 per share. | 01 Oct 2025 | 171 | 73,812 (0%) | 0% | 447.9 | 76,594 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 457.67 per share. | 01 Oct 2025 | 9 | 65,409 (0%) | 0% | 457.7 | 4,119 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 14,252 | 63,200 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 454.04 per share. | 15 Aug 2025 | 2,716 | 57,485 (0%) | 0% | 454.0 | 1,233,173 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 452.96 per share. | 15 Aug 2025 | 1,646 | 60,201 (0%) | 0% | 453.0 | 745,572 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 454.84 per share. | 15 Aug 2025 | 1,204 | 56,281 (0%) | 0% | 454.8 | 547,627 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 451.99 per share. | 15 Aug 2025 | 514 | 61,847 (0%) | 0% | 452.0 | 232,323 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 449.92 per share. | 15 Aug 2025 | 450 | 62,556 (0%) | 0% | 449.9 | 202,464 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 450.92 per share. | 15 Aug 2025 | 195 | 62,361 (0%) | 0% | 450.9 | 87,929 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 447.98 per share. | 15 Aug 2025 | 194 | 63,006 (0%) | 0% | 448.0 | 86,908 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 455.82 per share. | 15 Aug 2025 | 60 | 56,221 (0%) | 0% | 455.8 | 27,349 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 304.00 per share. | 30 May 2025 | 25,469 | 55,119 (0%) | 0% | 304 | 7,742,576 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 19,559 | 8,064 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.05 per share. | 30 May 2025 | 19,559 | 80,588 (0%) | 0% | 118.1 | 2,308,940 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 306.00 per share. | 30 May 2025 | 19,297 | 48,948 (0%) | 0% | 306 | 5,904,882 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.13 per share. | 30 May 2025 | 12,081 | 61,029 (0%) | 0% | 119.1 | 1,439,210 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 12,081 | 12,919 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 12,080 | 839 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.13 per share. | 30 May 2025 | 12,080 | 61,028 (0%) | 0% | 119.1 | 1,439,090 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.05 per share. | 30 May 2025 | 7,217 | 68,245 (0%) | 0% | 118.1 | 851,967 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 7,217 | 847 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 306.00 per share. | 30 May 2025 | 6,171 | 48,948 (0%) | 0% | 306 | 1,888,326 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 16 May 2025 | 8,376 | 48,948 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 May 2025 | 41,311 | 57,324 (0%) | 0% | 0 | Common Stock |